Tocilizumab Reduces Mortality and Ventilation in Seven Covid-19
The Following is a summary of “EFFICACY OF TOCILIMAB FOR HOSPITALIZED PATIES WITH COVID-19 Pneumonia and High Il-6 Levels: A Randomized Controlled Trial,” Published in the April 2025 Issue of of Infection by Sellarès-Nadal et al. Researchers Drived the Retrospective Study to Assess the Effficacy and Safety of An IL-6-Drivenized Treatment Strategy Using Tocilizumab in […]
Continue Reading